🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Another major milestone for the psychedelics field. Congratulations to the MAPS team!

1/4 It is with immense excitement & gratitude that we announce Vine Ventures's leading investment in Othership's 8M Series-A. Here's why we invested: vine.vc/blog/othership youtube.com/watch?v=Ut4vMC…

2/4 The only other times I felt this high conviction that an emerging community would touch so many lives globally were @Ethereum & MAPS. Othership isn't just a company offering novel modalities for mental health, it is the first to solve the bridge...

3/4...between online communities seeking connection and shared IRL experiences that are meaningful. Communities will be to the 2020s what platforms & marketplaces were to the 2010s & apps were to the 2000s - some of the most valuable assets on the planet.

4/4 As Othership expands with this fresh capital, we are so excited to witness a generation change their relationship with their own mental health. We are deeply grateful & so inspired by the vision & execution of Robbie Bent & his team. LFG

Appreciate the shoutout from Rick Doblin, Ph.D., of MAPS on the Joe Rogan show today. MAPS continues to lead one of the most important missions on the planet.

Toured Vine Ventures portfolio co. Psygen's lab a few weeks back. Talented chemists + high-tech equipment = 500g of GMP-quality MDMA created in this very room

11 investors predict a colorful, if difficult, future for psychedelic startups tcrn.ch/42Nh1kM by Anna Heim

Kicked off MAPS Psychedelic Science with a panel including Vine partner Daniel Tarockoff, JLS Fund, Next Titan Capital, and SkipIntroAdvisors moderated by KCSApr Discussed the latest in private and public psychedelic markets. Find us in Denver this week 🍄

Last week's Psychedelic Science was a landmark moment for the field. Great to see so many Vine portfolio co.'s represented - TRIPP Wellness, Bexson Biomedical, Apollo Neuro™, Psygen, Osmind, MAPS

Awesome coverage of TRIPP Wellness on CBS News last week. Enter a new dimension - we'll follow Nanea Reeves anywhere youtube.com/watch?v=gdG1x_…

Roland set so much of the groundwork for making psychedelics accessible to all. A true legend in the field and a great example for all of us on how to take the space forward with vigor, humility, and sincerity. thedalesreport.com/psychedelics/p…

Congratulations to Cordance Medical on FDA Breakthrough Device Designation! The first given to a device for a sonobiopsy procedure. Ryan Dittamore awesome achievement.

Interested in the psychedelics field and Chief of Staff roles? MAPS is hiring: linkedin.com/jobs/view/3750…

Vine Ventures is proud to participate in MAPS PBC (now Lykos) Series-A financing. This is a major step forward for mental health with FDA Phase III approval expected this year! We're proud that the Regenerative Financing Vine helped bridge MAPS to this moment.

A fair review of Othership by the cold plunge pro danawhite

Congratulations to Alto Neuroscience on getting listed at NYSE 🏛! We're excited for the journey ahead!

Congratulations Lykos Therapeutics (fka MAPS PBC) for securing FDA Acceptance and Priority Review! A big step forward for the whole space! news.lykospbc.com/2024-02-09-Lyk…